News Release

• 1.26, 2010

  IHI Corporation and UMN Pharma Announce Manufacturing Collaboration

• 10.05, 2009

  UMN Pharma initiates phase II clinical trial for avian influenza A (H5N1) vaccine manufactured from cell-culture, UMN-0501.

• 6.29, 2009

  Protein Sciences Corporation signs a contract which amounts to about 147 million dollars with U.S. Department of Health and Human Services for new way to make flu vaccine.

• 2.16, 2009

  UMN Pharma Secures additional investment from IPEC.

• 2.13, 2009

  UMN Pharma presents favorable results from Phase I/II study of UMN-0501 at World Health Organization (WHO) pandemic influenza meeting.

Archive